Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Feb 9, 2024 | Uncategorized
Characterization of the anti-tumor activity of memory cytokine enriched NK cells (M-ceNK) against tumors with neuroendocrine features Nov 7, 2023 | Uncategorized
The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques Jul 20, 2023 | HIV
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34(+) progenitor-derived NK cells Jul 20, 2023 | Uncategorized
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells Jul 19, 2023 | HIV
